Filter posts

Patent Cases Down by 40% in 2014

The number of new patent cases filed in federal court has dropped by an astonishing …

PTO Patent Examinations in the wake of Mayo and Myriad

Biotech patent applicants are finding themselves in uncharted waters.   After the Supreme Court’s decisions …

BIO Submits Comments on “Myriad” PTO Patent Guidance

On July 31st, BIO, alongside a group of international bioindustry trade associations submitted comments to …

Supreme Court Decision on Web Content Delivery to Impact Biotech Patents

Earlier this month, in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court issued …

Nautilus v. Biosig, Baxter v. Fresenius and Limelight v. Akamai

BIO weighed in on three Supreme Court cases in the last few months whose outcome …

Corporate-Sponsored University Research Valuable for Further Innovation

New research published in Nature, Technology Transfer: Industry-funded academic inventions boost innovation, provides data undermining …

Special 301: BIO Highlights Challenges in India

BIO recently testified before the U.S. government on the intellectual property challenges our members face …

TPP and IP: The Economic Benefits of a Pacific Trade Agreement

Ndp Analytics recently published a study on the economic benefits of intellectual property rights (IP) …

Patently Biotech’s Top Articles of 2013

Intellectual property featured prominently in 2013’s public discourse. Gene patents, patent trolls, India’s anti-patent actions, …

TRIPs Has Delivered: Patent Agreement Increases Drug Development

The TRIPs (Trade Related Aspects of Intellectual Property) Agreement, effective in 1996, has resulted in …